A5082582024- Antibiotics Pharmacokinetics and Efficacy
- Acute Kidney Injury Research
- Neurosurgical Procedures and Complications
- Intracranial Aneurysms: Treatment and Complications
- Hemodynamic Monitoring and Therapy
- Cerebrospinal fluid and hydrocephalus
- Poisoning and overdose treatments
- Traumatic Brain Injury and Neurovascular Disturbances
University of Alberta
2022-2024
Abstract Background Nimodipine improves outcomes following aneurysmal subarachnoid hemorrhage (aSAH) and current guidelines suggest that patients with aSAH receive nimodipine for 21 days. Patients no difficulty swallowing will swallow the whole capsules or tablets; otherwise, liquid must be drawn from capsules, tablets need to crushed, commercially available product used facilitate administration through an enteral feeding tube (FT). It is not clear whether these techniques are equivalent....
Background Nimodipine improves outcomes following aneurysmal subarachnoid hemorrhage (aSAH). Guidelines recommend that all patients should receive a fixed-dose nimodipine for 21 days. However, studies reported variability of concentrations in aSAH. It is not clear if reduced systemic exposure contributes to worsening outcomes. The aim this study was compare those who experienced poor favorable Methods This pilot prospective observational 30 adult admitted the University Alberta Hospital with...